908 Devices Acquires TRACE Analytics GmbH

908 Devices Acquires RedWave Technology

April 30, 2024

Manufacturing

908 Devices Inc. has acquired privately-held RedWave Technology, a maker of portable FTIR spectroscopic analyzers, expanding 908 Devices' portfolio of handheld and desktop chemical identification tools for forensics, pharma PAT, and industrial QC. The deal includes $45.0 million in cash and 1.5 million shares (approximately $53.5 million initial consideration) plus contingent stock consideration tied to future milestones.

Tomra Systems Acquires 80% Stake in C-Trace GmbH

October 24, 2024

Environmental Services

Norway-based Tomra Systems ASA has acquired an 80% stake in Germany-based digital waste management solutions provider C-Trace GmbH, with an option to purchase the remaining 20% from the founders after two years. The acquisition expands Tomra's digitalization capabilities across the recycling value chain and aims to accelerate C-Trace's international growth using Tomra's global footprint; C-Trace employs about 120 people and generates roughly 80% of its sales in Germany.

Bruker Acquires Dynamic Biosensors GmbH

October 2, 2024

Biotechnology

Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based developer of single-cell interaction cytometry and biosensor instruments, to strengthen Bruker’s biosensors portfolio. The deal combines Dynamic Biosensors’ heliXcyto and heliX+ technologies with Bruker’s high-throughput SPR systems to expand capabilities and product offerings for drug discovery and biopharma research; financial terms were not disclosed.

Tennaxia Acquires Traace

May 30, 2024

Cloud & SaaS

Tennaxia, a Marlin Equity Partners portfolio company, has acquired Traace, a Paris-based SaaS provider of carbon accounting and CSR solutions. The deal will merge Traace into Tennaxia to expand carbon accounting capabilities and create a stronger European sustainability software platform for middle-market and enterprise clients.

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

Bruker Corporation Majority Investment in RECIPE Chemicals + Instruments GmbH

April 16, 2025

Medical Devices

Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, a Munich-based provider of mass spectrometry‑based in vitro diagnostic assay kits for therapeutic drug monitoring. The deal (financial terms undisclosed) brings RECIPE's ClinMASS kits into Bruker's portfolio and creates a strategic collaboration to introduce high‑throughput, chromatography‑free ClinDART workflows on Bruker's EVOQ‑DART TQ⁺ platform.